vs

Side-by-side financial comparison of LCI INDUSTRIES (LCII) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $932.7M, roughly 1.6× LCI INDUSTRIES). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 2.0%, a 2.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 16.1%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $64.3M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -1.8%).

Lucky Core Industries Limited, formerly known as ICI Pakistan, is a Pakistani conglomerate company headquartered in Karachi. It manufactures polyester, pharmaceutical, agrochemical, soda ash, and veterinary medicine.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

LCII vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
1.6× larger
ONC
$1.5B
$932.7M
LCII
Growing faster (revenue YoY)
ONC
ONC
+16.7% gap
ONC
32.8%
16.1%
LCII
Higher net margin
ONC
ONC
2.4% more per $
ONC
4.4%
2.0%
LCII
More free cash flow
ONC
ONC
$315.5M more FCF
ONC
$379.8M
$64.3M
LCII
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
-1.8%
LCII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LCII
LCII
ONC
ONC
Revenue
$932.7M
$1.5B
Net Profit
$18.7M
$66.5M
Gross Margin
22.1%
90.5%
Operating Margin
3.8%
12.4%
Net Margin
2.0%
4.4%
Revenue YoY
16.1%
32.8%
Net Profit YoY
95.7%
143.8%
EPS (diluted)
$0.79
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LCII
LCII
ONC
ONC
Q4 25
$932.7M
$1.5B
Q3 25
$1.0B
$1.4B
Q2 25
$1.1B
$1.3B
Q1 25
$1.0B
$1.1B
Q4 24
$803.1M
$1.1B
Q3 24
$915.5M
$1.0B
Q2 24
$1.1B
$929.2M
Q1 24
$968.0M
$751.7M
Net Profit
LCII
LCII
ONC
ONC
Q4 25
$18.7M
$66.5M
Q3 25
$62.5M
$124.8M
Q2 25
$57.6M
$94.3M
Q1 25
$49.4M
$1.3M
Q4 24
$9.5M
$-151.9M
Q3 24
$35.6M
$-121.3M
Q2 24
$61.2M
$-120.4M
Q1 24
$36.5M
$-251.2M
Gross Margin
LCII
LCII
ONC
ONC
Q4 25
22.1%
90.5%
Q3 25
24.4%
86.1%
Q2 25
24.4%
87.5%
Q1 25
24.1%
85.2%
Q4 24
21.1%
85.8%
Q3 24
24.0%
83.0%
Q2 24
25.3%
85.1%
Q1 24
23.1%
83.4%
Operating Margin
LCII
LCII
ONC
ONC
Q4 25
3.8%
12.4%
Q3 25
7.3%
11.5%
Q2 25
7.9%
6.7%
Q1 25
7.8%
1.0%
Q4 24
2.0%
-7.0%
Q3 24
5.9%
-12.0%
Q2 24
8.6%
-11.5%
Q1 24
6.0%
-34.8%
Net Margin
LCII
LCII
ONC
ONC
Q4 25
2.0%
4.4%
Q3 25
6.0%
8.8%
Q2 25
5.2%
7.2%
Q1 25
4.7%
0.1%
Q4 24
1.2%
-13.5%
Q3 24
3.9%
-12.1%
Q2 24
5.8%
-13.0%
Q1 24
3.8%
-33.4%
EPS (diluted)
LCII
LCII
ONC
ONC
Q4 25
$0.79
$0.05
Q3 25
$2.55
$0.08
Q2 25
$2.29
$0.06
Q1 25
$1.94
$0.00
Q4 24
$0.37
$-0.10
Q3 24
$1.39
$-0.09
Q2 24
$2.40
$-0.09
Q1 24
$1.44
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LCII
LCII
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$222.6M
$4.5B
Total DebtLower is stronger
$945.2M
$836.4M
Stockholders' EquityBook value
$1.4B
$4.4B
Total Assets
$3.2B
$8.2B
Debt / EquityLower = less leverage
0.69×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LCII
LCII
ONC
ONC
Q4 25
$222.6M
$4.5B
Q3 25
$199.7M
$4.0B
Q2 25
$191.9M
$2.8B
Q1 25
$231.2M
$2.5B
Q4 24
$165.8M
$2.6B
Q3 24
$161.2M
$2.7B
Q2 24
$130.4M
$2.6B
Q1 24
$22.6M
$2.8B
Total Debt
LCII
LCII
ONC
ONC
Q4 25
$945.2M
$836.4M
Q3 25
$947.8M
Q2 25
$948.0M
Q1 25
$938.3M
Q4 24
$757.3M
Q3 24
$822.5M
Q2 24
$829.7M
Q1 24
$855.3M
Stockholders' Equity
LCII
LCII
ONC
ONC
Q4 25
$1.4B
$4.4B
Q3 25
$1.4B
$4.1B
Q2 25
$1.4B
$3.8B
Q1 25
$1.4B
$3.5B
Q4 24
$1.4B
$3.3B
Q3 24
$1.4B
$3.4B
Q2 24
$1.4B
$3.4B
Q1 24
$1.4B
$3.4B
Total Assets
LCII
LCII
ONC
ONC
Q4 25
$3.2B
$8.2B
Q3 25
$3.2B
$7.6B
Q2 25
$3.2B
$6.3B
Q1 25
$3.1B
$5.8B
Q4 24
$2.9B
$5.9B
Q3 24
$3.0B
$5.8B
Q2 24
$3.0B
$5.7B
Q1 24
$3.0B
$5.7B
Debt / Equity
LCII
LCII
ONC
ONC
Q4 25
0.69×
0.19×
Q3 25
0.70×
Q2 25
0.68×
Q1 25
0.69×
Q4 24
0.55×
Q3 24
0.58×
Q2 24
0.60×
Q1 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LCII
LCII
ONC
ONC
Operating Cash FlowLast quarter
$78.9M
$417.3M
Free Cash FlowOCF − Capex
$64.3M
$379.8M
FCF MarginFCF / Revenue
6.9%
25.4%
Capex IntensityCapex / Revenue
1.6%
2.5%
Cash ConversionOCF / Net Profit
4.22×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$278.3M
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LCII
LCII
ONC
ONC
Q4 25
$78.9M
$417.3M
Q3 25
$97.2M
$402.6M
Q2 25
$112.2M
$263.6M
Q1 25
$42.7M
$44.1M
Q4 24
$106.6M
$75.2M
Q3 24
$78.4M
$188.4M
Q2 24
$192.9M
$-95.6M
Q1 24
$-7.7M
$-308.6M
Free Cash Flow
LCII
LCII
ONC
ONC
Q4 25
$64.3M
$379.8M
Q3 25
$80.9M
$354.5M
Q2 25
$99.5M
$219.8M
Q1 25
$33.7M
$-12.3M
Q4 24
$95.7M
$-17.3M
Q3 24
$68.3M
$54.7M
Q2 24
$180.2M
$-205.5M
Q1 24
$-16.3M
$-465.1M
FCF Margin
LCII
LCII
ONC
ONC
Q4 25
6.9%
25.4%
Q3 25
7.8%
25.1%
Q2 25
9.0%
16.7%
Q1 25
3.2%
-1.1%
Q4 24
11.9%
-1.5%
Q3 24
7.5%
5.5%
Q2 24
17.1%
-22.1%
Q1 24
-1.7%
-61.9%
Capex Intensity
LCII
LCII
ONC
ONC
Q4 25
1.6%
2.5%
Q3 25
1.6%
3.4%
Q2 25
1.2%
3.3%
Q1 25
0.9%
5.0%
Q4 24
1.4%
8.2%
Q3 24
1.1%
13.3%
Q2 24
1.2%
11.8%
Q1 24
0.9%
20.8%
Cash Conversion
LCII
LCII
ONC
ONC
Q4 25
4.22×
6.28×
Q3 25
1.55×
3.22×
Q2 25
1.95×
2.79×
Q1 25
0.86×
34.71×
Q4 24
11.17×
Q3 24
2.20×
Q2 24
3.15×
Q1 24
-0.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LCII
LCII

Travel Trailer And Fifth Wheels$378.4M41%
Chassis Chassis Partsand Slideout Mechanisms$206.1M22%
Furnitureand Mattresses$120.4M13%
Appliances$69.9M7%
Other Products$69.1M7%
Axlesand Suspension Solutions$62.3M7%
Motorhomes$34.2M4%

ONC
ONC

Segment breakdown not available.

Related Comparisons